110 related articles for article (PubMed ID: 29668485)
1. Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor: a case report and literature review.
Raimondi A; Colombo F; Pintarelli G; Morosi C; Renne SL; Frezza AM; Saponara M; Dei Tos AP; Mazzocchi A; Provenzano S; Casali PG; Stacchiotti S
Anticancer Drugs; 2018 Jul; 29(6):589-595. PubMed ID: 29668485
[TBL] [Abstract][Full Text] [Related]
2. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ; Malinowska-Kolodziej I; Morgan JA; Qin W; Fletcher CD; Vena N; Ligon AH; Antonescu CR; Ramaiya NH; Demetri GD; Kwiatkowski DJ; Maki RG
J Clin Oncol; 2010 Feb; 28(5):835-40. PubMed ID: 20048174
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience.
Benson C; Vitfell-Rasmussen J; Maruzzo M; Fisher C; Tunariu N; Mitchell S; Al-Muderis O; Thway K; Larkin J; Judson I
Anticancer Res; 2014 Jul; 34(7):3663-8. PubMed ID: 24982384
[TBL] [Abstract][Full Text] [Related]
4. Phase II Trial of
Wagner AJ; Ravi V; Riedel RF; Ganjoo K; Van Tine BA; Chugh R; Cranmer L; Gordon EM; Hornick JL; Du H; Ding L; Schmid AN; Navarro WH; Kwiatkowski DJ; Dickson MA
J Clin Oncol; 2024 May; 42(13):1472-1476. PubMed ID: 38427923
[No Abstract] [Full Text] [Related]
5.
Wagner AJ; Ravi V; Riedel RF; Ganjoo K; Van Tine BA; Chugh R; Cranmer L; Gordon EM; Hornick JL; Du H; Grigorian B; Schmid AN; Hou S; Harris K; Kwiatkowski DJ; Desai NP; Dickson MA
J Clin Oncol; 2021 Nov; 39(33):3660-3670. PubMed ID: 34637337
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant or adjuvant sirolimus for malignant metastatic or locally advanced perivascular epithelioid cell tumors: two case reports.
Batereau C; Knösel T; Angele M; Dürr HR; D'Anastasi M; Kampmann E; Ismann B; Bücklein V; Lindner LH
Anticancer Drugs; 2016 Mar; 27(3):254-8. PubMed ID: 26645891
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).
Bergamo F; Maruzzo M; Basso U; Montesco MC; Zagonel V; Gringeri E; Cillo U
World J Surg Oncol; 2014 Feb; 12():46. PubMed ID: 24575738
[TBL] [Abstract][Full Text] [Related]
8. PEComa of the colon resistant to sirolimus but responsive to doxorubicin/ifosfamide.
Scheppach W; Reissmann N; Sprinz T; Schippers E; Schoettker B; Mueller JG
World J Gastroenterol; 2013 Mar; 19(10):1657-60. PubMed ID: 23539498
[TBL] [Abstract][Full Text] [Related]
9. Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors.
Sanfilippo R; Fabbroni C; Fucà G; Fumagalli E; Morosi C; Sbaraglia M; Gronchi A; Collini P; Dei Tos AP; Casali PG
Clin Cancer Res; 2020 Oct; 26(20):5534-5538. PubMed ID: 32605908
[TBL] [Abstract][Full Text] [Related]
10. An orbital perivascular epithelioid cell tumor in a 7-year-old boy: case report and review of the literature.
Varan A; Bayhan T; Kiratli H; Özoğul E; Kösemehmetoğlu K; Bulut E; Akyüz C
J AAPOS; 2017 Aug; 21(4):325-328.e1. PubMed ID: 28576480
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.
Stacchiotti S; Provenzano S; Dagrada G; Negri T; Brich S; Basso U; Brunello A; Grosso F; Galli L; Palassini E; Libertini M; Colia V; Gronchi A; Dei Tos AP; Crippa F; Morosi C; Pilotti S; Casali PG
Ann Surg Oncol; 2016 Sep; 23(9):2735-44. PubMed ID: 27334221
[TBL] [Abstract][Full Text] [Related]
12. Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa.
Italiano A; Delcambre C; Hostein I; Cazeau AL; Marty M; Avril A; Coindre JM; Bui B
Ann Oncol; 2010 May; 21(5):1135-7. PubMed ID: 20215136
[No Abstract] [Full Text] [Related]
13. Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature.
Starbuck KD; Drake RD; Budd GT; Rose PG
Anticancer Res; 2016 Nov; 36(11):6161-6164. PubMed ID: 27793946
[TBL] [Abstract][Full Text] [Related]
14. Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.
Alaggio R; Cecchetto G; Martignoni G; Bisogno G; Cheng L; Sperlì D; d'Amore ES; Dall'Igna P
J Pediatr Surg; 2012 Jun; 47(6):e31-40. PubMed ID: 22703822
[TBL] [Abstract][Full Text] [Related]
15. Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus.
Cetin B; Coskun U; Yildiz R; Buyukberber S; Baykara M; Benekli M
J Oncol Pharm Pract; 2011 Sep; 17(3):274-8. PubMed ID: 20215482
[TBL] [Abstract][Full Text] [Related]
16. First pancreatic perivascular epithelioid cell tumor (PEComa) treated by mTOR inhibitor.
Gondran H; Thebaud E; Moreau A; Le Rhun M; Touchefeu Y; Regenet N; Musquer N
Pancreatology; 2019 Jun; 19(4):566-568. PubMed ID: 31130397
[TBL] [Abstract][Full Text] [Related]
17. HMB-45 negative multifocal malignant perivascular epithelioid cell tumor of the soft tissue responding to sirolimus: First case report from India.
Kapoor A; Beniwal S; Singhal MK; Kumar N; Kumar V; Kumar HS
J Cancer Res Ther; 2015; 11(4):1036. PubMed ID: 26881640
[TBL] [Abstract][Full Text] [Related]
18. Resistance to mammalian target of rapamycin inhibitor therapy in perivascular epithelioid cell tumors.
Subbiah V; Trent JC; Kurzrock R
J Clin Oncol; 2010 Aug; 28(24):e415. PubMed ID: 20567010
[No Abstract] [Full Text] [Related]
19. Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer.
Mbatchi LC; Gassiot M; Pourquier P; Goberna A; Mahammedi H; Mourey L; Joly F; Lumbroso S; Evrard A; Houede N
Cancer Chemother Pharmacol; 2017 Sep; 80(3):653-659. PubMed ID: 28676933
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial.
Wataya-Kaneda M; Nakamura A; Tanaka M; Hayashi M; Matsumoto S; Yamamoto K; Katayama I
JAMA Dermatol; 2017 Jan; 153(1):39-48. PubMed ID: 27837201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
